Evidence map›Paper›PMID 30473698›Full record

ReviewFrontiers in immunology2018

The Key Role of TNF-TNFR2 Interactions in the Modulation of Allergic Inflammation: A Review.

Suhana Ahmad, Nor Azrini Azid, Jennifer C Boer, JitKang Lim, Xin Chen, Magdalena Plebanski, Rohimah Mohamud

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 104 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Suhana AhmadDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
Nor Azrini AzidDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
Jennifer C BoerDepartment of Immunology and Pathology, Monash University, Melbourne, VIC, Australia.
JitKang LimSchool of Chemical Engineering, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Xin ChenState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, China.
Magdalena PlebanskiSchool of Health and Biomedical Sciences, RMIT, Melbourne, VIC, Australia.
Rohimah MohamudDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
Universiti Sains Malaysia · MYHospital Universiti Sains Malaysia · MYMonash University · AURMIT University · AUUniversity of Macau · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor necrosis factor-alpha (TNF) is a pleiotropic cytokine, which is thought to play a major role in the pathogenesis of inflammatory diseases, including allergy. TNF is produced at the early stage of allergen sensitization, and then continues to promote the inflammation cascade in the effector phase of allergic reactions. Consequently, anti-TNF treatment has been proposed as a potential therapeutic option. However, recent studies reveal anti-intuitive effects of TNF in the activation and proliferative expansion of immunosuppressive Tregs, tolerogenic DCs and MDSCs. This immunosuppressive effect of TNF is mediated by TNFR2, which is preferentially expressed by immunosuppressive cells. These findings redefine the role of TNF in allergic reaction, and suggest that targeting TNF-TNFR2 interaction itself may represent a novel strategy in the treatment of allergy.

Indexed as

AnimalsHumansHypersensitivityImmunosuppression TherapyInflammationReceptors, Tumor Necrosis Factor, Type IITumor Necrosis Factor-alphaReceptors, Tumor Necrosis Factor, Type IITumor Necrosis Factor-alphaallergyregulatory T cellsTNFTNFR2tolerogenic dendritic cells

Identifiers

PMID30473698
PMCPMC6238659
OpenAlexW2900444177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.